EarningsQ3 2025 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q3 2025 Earnings Report

0 Followers

MX:JAZZN Q3 2025 EPS Results

Actual EPS$149.52

Consensus EPS$109.35

Beat/MissBeat by +$40.17

One Year Ago EPS$121.57

Actual Revenue$20.71B

Expected Revenue$20.43B

Beat/MissBeat by +$275.68M

YoY Revenue Growth+6.74%

QuarterQ3 2025

Date11/05/2025

TimeAfter Close

Conference CallWednesday, November 5, 2025

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	117.46 / -	149.52	―
Aug 03, 2026	2026 (Q2)	113.57 / 105.01	-151.727	169.21% (+256.74)
May 05, 2026	2026 (Q1)	85.35 / 116.60	30.897	277.38% (+85.70)
Feb 24, 2026	2025 (Q4)	119.87 / 122.12	121.382	0.61% (+0.74)
Nov 05, 2025	2025 (Q3)	109.35 / 149.52	121.565	23.00% (+27.95)
Aug 05, 2025	2025 (Q2)	-139.88 / -151.73	97.473	-255.66% (-249.20)
May 06, 2025	2025 (Q1)	85.67 / 30.90	49.288	-37.31% (-18.39)
Feb 25, 2025	2024 (Q4)	107.81 / 121.38	92.324	31.47% (+29.06)
Nov 06, 2024	2024 (Q3)	101.11 / 121.57	89.013	36.57% (+32.55)
Jul 31, 2024	2024 (Q2)	90.52 / 97.47	82.944	17.52% (+14.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed